Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments
- 14 April 2011
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 179, 208-222
- https://doi.org/10.1016/j.neuroscience.2011.01.033
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticityJournal of Neural Transmission, 2009
- Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxinVaccine, 2009
- Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light ChainPLOS ONE, 2008
- The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum ToxinJournal of Pharmacology and Experimental Therapeutics, 2008
- Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal RouteInfection and Immunity, 2007
- Molecular Bases of Protective Immune Responses against BotuIInum Neurotoxin A—How Antitoxin Antibodies Block Its ActionCritical Reviews in Immunology, 2007
- An Initial Assessment of the Systemic Pharmacokinetics of Botulinum ToxinJournal of Pharmacology and Experimental Therapeutics, 2006
- Four molecules of the 33 kDa haemagglutinin component of the Clostridium botulinum serotype C and D toxin complexes are required to aggregate erythrocytesMicrobiology, 2005
- Therapeutic Uses of Botulinum ToxinNew England Journal of Medicine, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970